Investor Presentation
NZX Code: ATM
ASX Code: A2M
17 October 2018
NZX/ASX Market Release
Investor Presentation
Please find attached a presentation to be given today by The a2 Milk Company Limited at Citi’s 10
th
Annual
Australian and New Zealand Investment Conference in Sydney.
An update on progress in the Company’s key markets during the first quarter of FY19 is provided on page 26.
There is no change to the Company’s FY19 outlook statement, set out on page 28.
The next update on performance is expected to be provided at the time of the Company’s Annual Meeting on
20 November 2018.
The a2 Milk Company Limited
Jayne Hrdlicka
Managing Director & CEO
│
•
•
•
•
•
•
•
↑
↑
•
•
•
→
→
→
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
15
ā
•
–
–
–
–
–
–
•
–
–
–
–
•
•
•
•
•
•
•
•
–
–
•
–
–
–
–
•
–
–ā
•
•
•
–
–
–
–
–
•
•
•
•
•
–
•
–
–
•
•
–
–
•
•
•
•
•
•
•
–
–
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AFT — AFT Pharmaceuticals Limited: AFT Annual Meeting 2018 Presentation2018-08-02
“AFTPHARMACEUTICALS Annual Meeting 3 August 2018 Annual Meeting 2 August 2018 1 IMPORTANT NOTICE This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”), to provide a general overview of AFT. It is not prepared for any other purpose and must not be provided to…”
- AFT — AFT Pharmaceuticals Limited: FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 20182018-11-21
“AFT is a company incorporated with limited liability under the New Zealand Companies Act 1993 (Companies Office registration number 873005). Registered OfficeLevel 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand +64 9 488 0232 www.aftpharm.com Mertons, Level 7, 33…”
- SML — Synlait Milk Limited: Synlait October Conference Presentation2018-10-24
“A PORTFOLIO OF INFANT FORMULA CUSTOMER PARTNERSHIPS - Registration with State Administration for Market Regulation (SAMR - the replacement organisation for CFDA) received in FY18 - Exclusive supplier of the a2 Milk Company’s TM infant formula to China and Australasia mar…”